Registration number: 05506872

Tinfloyd Healthcare Limited

Contents

Company Information	1
Balance Sheet	2
Notes to the Unaudited Financial Statements	3 to 9

Tinfloyd Healthcare Limited

Company Information

Directors

Mrs L K Floyd Mr M D Floyd

Registered office

Ashtree House Church Lane Withern Alford Lincolnshire LN13 0NG

Tinfloyd Healthcare Limited

(Registration number: 05506872)
Balance Sheet as at 30 July 2025

	Note	2025 £	2024 £
Fixed assets
Intangible assets	4	45,788	67,663
Tangible assets	5	926,234	927,707
		972,022	995,370
Current assets
Stocks	6	500	500
Debtors	7	117,359	108,059
Cash at bank and in hand		77,693	10,940
		195,552	119,499
Creditors: Amounts falling due within one year	8	(139,705)	(102,250)
Net current assets		55,847	17,249
Total assets less current liabilities		1,027,869	1,012,619
Creditors: Amounts falling due after more than one year	8	(653,057)	(690,077)
Provisions for liabilities		(7,547)	(7,675)
Net assets		367,265	314,867
Capital and reserves
Called up share capital	9	300,000	300,000
Retained earnings		67,265	14,867
Shareholders' funds		367,265	314,867

For the financial year ending 30 July 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the Company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the Directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 July 2026 and signed on its behalf by:
 

......................................... Mrs L K Floyd Director

Tinfloyd Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 July 2025

1	General information

The address of its registered office is:
Ashtree House
Church Lane
Withern
Alford
Lincolnshire
LN13 0NG

These financial statements were authorised for issue by the Board on 30 July 2026.

The company is a private company limited by share capital incorporated in England & Wales and the company registration number is 05506872.

These financial statements cover the individual entity, Tinfloyd Healthcare Limited.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in sterling and are rounded to the nearest pound.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Tinfloyd Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 July 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Land and buildings	NIL
Plant & Machinery	15% & 33% reducing balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the Company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Goodwill	5% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Tinfloyd Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 July 2025

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences. Deferred tax on revalued non-depreciable tangible fixed assets and investment properties is measured using the rates and allowances that apply to the sale of the asset.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3	Staff numbers

The average number of persons employed by the Company (including Directors) during the year, was 37 (2024 - 35).

Tinfloyd Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 July 2025

4	Intangible assets

	Goodwill  £	Total £
Cost or valuation
At 31 July 2024	437,500	437,500
At 30 July 2025	437,500	437,500
Amortisation
At 31 July 2024	369,837	369,837
Amortisation charge	21,875	21,875
At 30 July 2025	391,712	391,712
Carrying amount
At 30 July 2025	45,788	45,788
At 30 July 2024	67,663	67,663

5	Tangible assets

	Land and buildings £	Furniture, fittings and equipment  £	Total £
Cost or valuation
At 31 July 2024	917,922	69,493	987,415
At 30 July 2025	917,922	69,493	987,415
Depreciation
At 31 July 2024	-	59,708	59,708
Charge for the year	-	1,473	1,473
At 30 July 2025	-	61,181	61,181
Carrying amount
At 30 July 2025	917,922	8,312	926,234
At 30 July 2024	917,922	9,785	927,707

Included within the net book value of land and buildings above is £917,922 (2024 - £917,922) in respect of freehold land and buildings.
 

6

Stocks

	2025 £	2024 £
Finished goods and goods for resale	500	500

Tinfloyd Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 July 2025

7

Debtors

Current	2025 £	2024 £
Prepayments	1,872	-
Other debtors	115,487	108,059
	117,359	108,059

Details of non-current trade and other debtors

£100,000 (2024 -£100,000) of Unpaid share capital is classified as non current.

8

Creditors

Creditors: amounts falling due within one year

	Note	2025 £	2024 £
Due within one year
Loans and borrowings	10	45,000	46,219
Trade creditors		3,316	3,029
Taxation and social security		41,221	12,947
Accruals and deferred income		4,030	3,840
Other creditors		46,138	36,215
		139,705	102,250

Creditors include bank loans and overdrafts which are secured of £40,000 (2024 - £40,000).

Creditors: amounts falling due after more than one year

	Note	2025 £	2024 £
Due after one year
Loans and borrowings	10	653,057	690,077

	2025 £	2024 £
Due after more than five years
After more than five years by instalments	436,568	468,458

	-	-